Grantham, Mayo, Van Otterloo & Co (GMO)
ARMK icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Aramark ARMK Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ARMK Stock Details ARMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$165M Sell
2,893,600
-30,133
-1% -$1.49M 0.37% 39
2026
Q1 		$119M Buy
2,923,733
+391,704
+15% +$15.5M 0.3% 45
2025
Q4 		$93.3M Sell
2,532,029
-356,659
-12% -$13.6M 0.24% 46
2025
Q3 		$111M Buy
2,888,688
+227,301
+9% +$9.2M 0.31% 38
2025
Q2 		$111M Buy
2,661,387
+248,588
+10% +$9.23M 0.34% 38
2025
Q1 		$83.3M Buy
2,412,799
+1,006,448
+72% +$37.1M 0.26% 40
2024
Q4 		$52.5M Buy
1,406,351
+189,001
+16% +$7.35M 0.17% 62
2024
Q3 		$47.1M Buy
1,217,350
+534,426
+78% +$18.9M 0.15% 94
2024
Q2 		$23.2M Buy
682,924
+275,540
+68% +$8.94M 0.08% 168
2024
Q1 		$13.2M Buy
407,384
+295,757
+265% +$8.91M 0.05% 232
2023
Q4 		$3.14M Buy
111,627
+16,408
+17% +$445K 0.01% 324
2023
Q3 		$2.39M Buy
95,219
+8,237
+9% +$231K 0.01% 392
2023
Q2 		$2.7M Buy
86,982
+15,628
+22% +$426K 0.01% 410
2023
Q1 		$1.84M Buy
71,354
+6,335
+10% +$180K 0.01% 427
2022
Q4 		$1.94M Hold
65,019
– – 0.01% 436
2022
Q3 		$1.47M Hold
65,019
– – 0.01% 455
2022
Q2 		$1.44M Sell
65,019
-5,124
-7% -$127K 0.01% 477
2022
Q1 		$1.9M Buy
70,143
+5,062
+8% +$132K 0.01% 456
2021
Q4 		$1.73M Buy
65,081
+5,807
+10% +$152K 0.01% 482
2021
Q3 		$1.41M Sell
59,274
-19,613
-25% -$485K 0.01% 498
2021
Q2 		$2.12M Buy
78,887
+3,127
+4% +$85.8K 0.01% 455
2021
Q1 		$2.07M Buy
+75,760
New +$2.08M 0.01% 475
2020
Q1 		– Sell
-6,582
Closed -$206K – 748
2019
Q4 		$206K Sell
6,582
-67,611
-91% -$2.12M ﹤0.01% 653
2019
Q3 		$2.33M Sell
74,193
-31,163
-30% -$876K 0.02% 401
2019
Q2 		$2.74M Buy
+105,356
New +$2.46M 0.02% 401

Other funds holding ARMK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ARMK Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Aramark (ARMK) stake by 1% in Q2 2026, selling an estimated $1.49M and leaving 2,893,600 shares worth $165M. The position accounts for 0.37% of the portfolio, ranked #39.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ARMK in Q2 2019 and has held it in 25 quarters since. 549 funds tracked by Wall St. Rank hold ARMK as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 2,893,600 shares of Aramark worth $165M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 30,133 Aramark shares in Q2 2026, an estimated $1.49M.
  • Aramark made up 0.37% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #39 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Aramark in Q2 2019 and has held it in 25 quarters since.
  • 549 funds tracked by Wall St. Rank held Aramark as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.